INMB vs MAS · rev $50.0K vs P/E 18, rev $7.56B
INmune Bio Inc (INMB) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
INMB currently screens at market cap $33.5M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the INMB and MAS stock pages for the full models.
Not investment advice.